Andreas Schröeder - Concepedia

Author

Andreas Schröeder

Also Known As

A Schroeder, A. Schroeder, Andreas Schroeder, Andreas Schröeder, Birgit Scheel, Schroeder, Andreas

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Andreas Schröeder is an author at Merck (Germany) specializing in immunology, radiation oncology, and tumor immunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	35
2	Immunology	1	1	35
3	Pathology	1	1	35
4	Pharmacology	1	1	35
5	Cancer Therapeutics	1	1	35

Andreas Schröeder

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The RIN: an RNA integrity number for assigning integrity values to RNA measurements Andreas Schröeder, Odilo Mueller, Susanne Stocker, BMC Molecular Biology	2006	2.6K
A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients. Nehal J. Lakhani, Amita Patnaik, John B. Liao, Journal of Clinical Oncology ImmunologyPathologySolid TumorPharmacotherapyImmunotherapeutics	2020	35
The <i>Justy</i> mutation identifies <i>Gon4-like</i> as a gene that is essential for B lymphopoiesis Ping Lü, Isaiah L. Hankel, Judit Knisz, The Journal of Experimental Medicine	2010	26
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma Julius Strauss, Jean‐Laurent Deville, Mario Sznol, Journal for ImmunoTherapy of Cancer	2023	23
Abstract 2269: ATR inhibitor M6620 enhances anti-tumor efficacy of the combination of the anti-PD-L1 antibody avelumab with platinum-based chemotherapy Marat Alimzhanov, Patricia Soulard, Astrid Zimmermann, Cancer Research	2019	10

Page 1